Table 1

Baseline characteristics

Overall
n155 934
Sex, male (%)79 969 (51.3)
Age (median (IQR))75 (65–83)
Comorbidities, n (%)
 Ischaemic heart disease33 114 (21.2)
 Heart failure26 416 (17.0)
 Valvular atrial fibrillation1896 (1.2)
 Congenital heart disease409 (0.3)
 Chronic obstructive pulmonary disease17 660 (11.3)
 Autoimmune disorders1708 (1.1)
 Chronic kidney disease6265 (4.0)
 Syncope8681 (5.6)
 Hypertension61 898 (39.7)
 Sick sinus node (%)1381 (0.9)
 AV block grade 2 (%)303 (0.2)
 AV block grade 1 (%)221 (0.1)
 Bradycardia, unspecified (%)1133 (0.7)
Procedures
 PCI4776 (3.1)
 CABG2335 (1.5)
Pharmacotherapy
 Loop diuretics30 560 (19.6)
 Non-loop diuretics47 638 (30.6)
 RAS-inhibitors47 045 (30.2)
 Betablocker39 768 (25.5)
 CCBs34 715 (22.3)
 ASA52 198 (33.5)
  • Autoimmune disorders are systemic lupus erythematosus, rheumatoid arthritis and scleroderma.

  • ASA, acetylsalicylic acid; AV, atrioventricular; CABG, coronary artery bypass graft; CCBs, calcium channel blockers; PCI, percutaneous coronary intervention; RAS-inhibitors, renin-angiotensin inhibitors.